Citadel Advisors’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-16,285
| Closed | -$15.3K | – | 6812 |
|
2023
Q1 | $15.3K | Sell |
16,285
-13,534
| -45% | -$12.7K | ﹤0.01% | 5444 |
|
2022
Q4 | $14K | Buy |
29,819
+13,165
| +79% | +$6.18K | ﹤0.01% | 5622 |
|
2022
Q3 | $22K | Buy |
+16,654
| New | +$22K | ﹤0.01% | 5520 |
|
2022
Q2 | – | Sell |
-14,598
| Closed | -$35K | – | 7291 |
|
2022
Q1 | $35K | Buy |
+14,598
| New | +$35K | ﹤0.01% | 6018 |
|